http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022502403-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6903 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61 |
| filingDate | 2019-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022502403-A |
| titleOfInvention | Degradable hyaluronic acid hydrogel |
| abstract | The present invention relates to a conjugate comprising crosslinked hyaluronic acid in which multiple drug moieties are covalently and reversibly conjugated, the hyaluronic acid exhibits a certain degree of modification and comprises a degradable crosslinking agent moiety. .. The present invention also relates to their use as pharmaceuticals and their use in the diagnosis, prevention and treatment of diseases. [Selection diagram] None |
| priorityDate | 2018-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1793.